Personalis to Participate at Upcoming Investor Conferences
Personalis, Inc. (PSNL) will participate in investor conferences including BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference and 44th Annual Cowen Healthcare Conference. The company's management team will present at these events to engage with potential investors and showcase their advanced genomics for cancer.
01/31/2024 - 04:01 PM
FREMONT, Calif. --(BUSINESS WIRE)--
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will participate at the following investor conferences:
BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Snowbird, UT
44th Annual Cowen Healthcare Conference
Boston, MA
About Personalis, Inc.
At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care from biopsy through the life of the patient. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest time points, enable the selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California . To learn more, visit www.personalis.com and connect with us on LinkedIn and X (Twitter) .
View source version on businesswire.com: https://www.businesswire.com/news/home/20240131261127/en/
Investors:
investors@personalis.com
Media Contact:
pr@personalis.com
Source: Personalis, Inc.
When and where will Personalis, Inc. (PSNL) participate in investor conferences?
Personalis, Inc. (PSNL) will participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 13, 2024 at The Cliff Lodge in Snowbird, UT and 44th Annual Cowen Healthcare Conference on Wednesday, March 6, 2024 at 12:50 p.m. Eastern Time at the Boston Marriott Copley Place in Boston, MA.
What is the ticker symbol for Personalis, Inc.?
The ticker symbol for Personalis, Inc. is PSNL.
What will Personalis, Inc. present at the investor conferences?
Personalis, Inc. will present its advanced genomics for cancer at the investor conferences to engage with potential investors.
PSNL Rankings
#4996 Ranked by Stock Gains
PSNL Stock Data
Industry
Medical Laboratories
Sector
Health Care and Social Assistance
Tags
Biotechnology, Health Technology, Health Care and Social Assistance, Medical Laboratories
Country
US
City
Menlo Park
About PSNL
personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.
